425: Strive-Semler Merger: Cautionary Statement on Risks

Strive, Inc. and Semler Scientific, Inc. issued a communication regarding their proposed business combination, emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. and Semler Scientific, Inc. are proceeding with a proposed business combination.
• The communication, posted on X.com by Strive's CFO Ben Pham and CMO Arshia Sarkhani on September 22, 2025, serves as a Form 425 filing.
• The filing includes a comprehensive cautionary statement regarding forward-looking statements related to the merger.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the transaction.
• The S-4 will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders to approve the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when available for important information.

Sentiment

Score: 4

Explanation: The filing is a standard regulatory communication about a proposed merger, heavily weighted towards disclosing extensive risk factors and cautionary statements, leading to a slightly cautious sentiment despite the underlying positive intent of a merger.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the business combination.

Negatives

• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships could occur.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of closing, and the ability to successfully integrate businesses, are considered forward-looking statements. These are subject to inherent risks and uncertainties that could cause actual results to differ materially from anticipated results.

Management Comments

• The communication was posted on X.com by Ben Pham, Chief Financial Officer of Strive, Inc., and Arshia Sarkhani, Chief Marketing Officer of Strive.

Industry Context

This filing is a standard regulatory disclosure for a proposed business combination, a common strategy for companies seeking growth, market consolidation, or diversification. The extensive risk factor disclosure is typical for such transactions, reflecting regulatory requirements and investor caution in complex M&A environments.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor for the proposed transaction.

Related Party Transactions

• Semler Scientific's transactions with related persons are detailed in the section entitled 'TRANSACTIONS WITH RELATED PERSONS' included in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders, filed with the SEC on July 17, 2025.

Stakeholder Impact

• Shareholders of Semler Scientific will be asked to approve the proposed transaction, and their ownership will be affected by Strive's issuance of additional shares.
• Customers of Strive and Semler Scientific may have adverse reactions or changes to business relationships due to the announcement or completion of the proposed transaction.
• Employees of Strive and Semler Scientific may experience changes to their relationships or employment conditions as a result of the merger.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Recommendation

This filing is a procedural communication regarding a proposed business combination and primarily serves to highlight forward-looking statements and associated risks. It does not contain new financial results or operational updates that would warrant a 'buy' or 'sell' recommendation at this stage. A 'hold' recommendation is appropriate as investors await the comprehensive Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus, which will provide detailed financial, operational, and strategic information necessary for a more informed investment decision.

Keywords

Merger, Business Combination, SEC Filing, Strive Inc., Semler Scientific Inc., Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Stock Issuance